Blood and urine tests to track cervical cancer after treatment
Part of Cancer, Women’s health & pregnancy clinical trials.
This study tests whether DNA found in blood and urine can help detect cervical cancer and monitor it after treatment. If you’re newly diagnosed, these minimally invasive samples may help doctors follow your disease more easily over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older when you sign consent
- Have a new diagnosis of cervical cancer
- Be able and willing to follow the study steps as the study team asks
- You cannot be pregnant during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a personalized blood test that looks for tumor DNA to monitor cervical cancer and help guide treatment decisions. It is for people with advanced or returning cervical cancer who haven't started treatment yet.
This trial checks how well cervical cancer responds to surgery, radiation, and chemotherapy by measuring HPV DNA and RNA in blood and cervical mucus. It aims to improve monitoring during treatment.
This study looks at whether monitoring HPV DNA in your blood after surgery can help predict if cervical cancer comes back, and whether this information can guide decisions about extra treatment. If you join, you'll provide blood samples before and after surgery to track your HPV levels.
This observational study checks whether a blood test (a “cfDNA” test) can detect early signs of cancer or small amounts of cancer left after treatment. It may help doctors use a simple blood sample to improve cancer detection and follow-up.
This trial tests if a special blood test (called minimal residual disease testing) can find leftover cancer cells early in people with endometrial or cervical cancer. The goal is to see if this test can detect a return of cancer sooner than standard scans or exams.
This study looks at whether certain markers in your blood (DNA from cancer cells and HPV) can help predict how well you do after first treatment for cervical cancer that has come back or spread. You would have extra blood draws during follow-up visits.
Hear when a new Cervical Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.